Loeb & Loeb LLP is proud to sponsor the FDLI Advertising & Promotion Conference taking place from October 13-15, 2021 where partner Scott Liebman will be moderating the panel “The Current State of Unbranded Promotion and Disease Awareness” on October 14, and partner Jim Czaban will be moderating the panel “Industry Impact from FDA’s New “Intended Use” Rule” on October 15.
About the event:
A virtual format will enable innovative learning opportunities, increased schedule flexibility, and a new level of interaction between regulatory practitioners, industry experts, and government officials. Speakers will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics. Sessions will explore updated government agency initiatives, goals, and priorities, product promotion in a remote environment, social media best practices, trends in pre- approval communications, effective patient engagement, and litigation risks.
For more information, including how to register, please visit the event website.